PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy?
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference97 articles.
1. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018
2. Inhibitory B7-family molecules in the tumour microenvironment;Zou;Nat Rev Immunol,2008
3. The diverse functions of the PD1 inhibitory pathway;Sharpe;Nat Rev Immunol,2018
4. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition;Hui;Science,2017
5. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death;Ishida;EMBO J,1992
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Engineering PD-L1 targeted liposomal canagliflozin achieves multimodal synergistic cancer therapy;Chemical Engineering Journal;2024-10
2. New horizons in the mechanisms and therapeutic strategies for PD-L1 protein degradation in cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09
3. The role of RNA methylation in tumor immunity and its potential in immunotherapy;Molecular Cancer;2024-06-20
4. C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein–Protein Interaction;Molecules;2024-06-04
5. pH-responsive self-assembling peptides potentiate therapeutic efficacy via prolonged drug retention and immunomodulation;Materials & Design;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3